Abstract
Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have